Richard Hynes | |
---|---|
Born | Richard Olding Hynes [1] 29 November 1944 [2] |
Citizenship | American British [3] |
Education | University of Cambridge (BA, MA) Massachusetts Institute of Technology (PhD) |
Known for | Cell adhesion research Discovery of fibronectin |
Awards | Canada Gairdner International Award E.B. Wilson Medal Robert J. and Claire Pasarow Foundation Medical Research Award Albert Lasker Award for Basic Medical Research |
Scientific career | |
Fields | Cell biology |
Institutions | Massachusetts Institute of Technology Howard Hughes Medical Institute Broad Institute |
Thesis | Regulation of gene expression during early cleavage in sea urchin embryos (1971) |
Doctoral advisor | Paul R. Gross |
Doctoral students | Denisa Wagner |
Richard Olding Hynes FRS (born 29 November 1944) is a British biologist, a Howard Hughes Medical Institute Investigator, [4] and the Daniel K. Ludwig Professor for Cancer Research at the Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology (MIT). [5] His research focuses on cell adhesion and the interactions between cells and the extracellular matrix, with a particular interest in understanding molecular mechanisms of cancer metastasis. [5] He is well known as a co-discoverer of fibronectin molecules, a discovery that has been listed by Thomson Scientific ScienceWatch as a Nobel Prize candidate. [6]
Hynes earned his B.A. in 1966 and M.A. in 1970 from the University of Cambridge, both in biochemistry. He received his Ph.D. in biology from the Massachusetts Institute of Technology in 1971. He worked as a postdoctoral fellow at the Imperial Cancer Research Fund from 1971 to 1974. [4] [5] [7]
Hynes became a faculty member in the biology department at MIT in 1973 and was promoted to full professor in 1983. He was awarded Howard Hughes Medical Institute Investigator status in 1988. He served as the head of the biology department from 1989 to 1991 and as the director of the MIT Center for Cancer Research from 1991 to 2001, and became the Daniel K. Ludwig Professor for Cancer Research and affiliated with the Koch Institute for Integrative Cancer Research in 1999. Since 2004 he has been an associate member of the Broad Institute. [7] [8]
Hynes served as the president of the American Society for Cell Biology in 2000. [7] He has been a member of the Board of Governors of the Wellcome Trust since 2007. [9] He also served on the Life Sciences jury for the Infosys Prize in 2012.
He has also published on public policy and participated in the development of United States research guidelines for stem cell research, particularly embryonic stem cells. [10]
David Baltimore is an American biologist, university administrator, and 1975 Nobel laureate in Physiology or Medicine. He is a professor of biology at the California Institute of Technology (Caltech), where he served as president from 1997 to 2006. He founded the Whitehead Institute and directed it from 1982 to 1990. In 2008, he served as president of the American Association for the Advancement of Science in 2008.
Susan Hockfield is an American neuroscientist who served as the sixteenth president of the Massachusetts Institute of Technology from December 2004 through June 2012. Hockfield succeeded Charles M. Vest and was succeeded by L. Rafael Reif, who had served in her administration as Provost. Hockfield was the first biologist and the first woman to serve as the Institute's president. Hockfield currently serves as a Professor of Neuroscience in MIT's Department of Brain and Cognitive Sciences, a Joint Professor of Work and Organization Studies in MIT’s Sloan School of Management, and a member of the Koch Institute for Integrative Cancer Research. She is also a director of Break Through Cancer, Cajal Neuroscience, Fidelity Non-Profit Management Foundation, Lasker Foundation, Mass General Brigham, Pfizer, Repertoire Immune Medicines, and the Whitehead Institute for Biomedical Research; a lifetime member of the MIT Corporation; and a board member of the Belfer Center at the Harvard Kennedy School of Government. Before returning to MIT following her presidency, Hockfield held the Marie Curie Visiting Professorship at Harvard University's John F. Kennedy School of Government.
Phillip Allen Sharp is an American geneticist and molecular biologist who co-discovered RNA splicing. He shared the 1993 Nobel Prize in Physiology or Medicine with Richard J. Roberts for "the discovery that genes in eukaryotes are not contiguous strings but contain introns, and that the splicing of messenger RNA to delete those introns can occur in different ways, yielding different proteins from the same DNA sequence". He has been selected to receive the 2015 Othmer Gold Medal.
Sir Martin John EvansFLSW is an English biologist who, with Matthew Kaufman, was the first to culture mice embryonic stem cells and cultivate them in a laboratory in 1981. He is also known, along with Mario Capecchi and Oliver Smithies, for his work in the development of the knockout mouse and the related technology of gene targeting, a method of using embryonic stem cells to create specific gene modifications in mice. In 2007, the three shared the Nobel Prize in Physiology or Medicine in recognition of their discovery and contribution to the efforts to develop new treatments for illnesses in humans.
Peter Walter is a German-American molecular biologist and biochemist. He is currently the Director of the Bay Area Institute of Science at Altos Labs and an emeritus professor at the Department of Biochemistry and Biophysics of the University of California, San Francisco (UCSF). He was a Howard Hughes Medical Institute (HHMI) Investigator until 2022.
Sir Michael John Berridge was a British physiologist and biochemist.
Arthur D. Lander an American biologist who is Director of the Center for Complex Biological Systems at the University of California, Irvine.
Erkki Ruoslahti is a cancer researcher and distinguished professor at Sanford Burnham Prebys Medical Discovery Institute. He moved from Finland to the United States in 1976.
Timothy "Tim" A. Springer is an immunologist and the Latham Family Professor at Harvard Medical School. He is also a professor at the Department of Biological Chemistry and Molecular Pharmacology and of the Division of Medical Sciences, and a Senior Investigator at the Research Program in Cellular and Molecular Medicine of the Boston Children's Hospital. Springer is best known for discovering the first integrins, LFA-1, and intercellular adhesion molecules (ICAMs), and for elucidating how these cell adhesion molecules function in the immune system. In recent years, Springer's research interest has expanded to malaria, transforming growth factor beta (TGF-β) signaling, and von Willebrand factor.
Brigid L. M. Hogan FRS is a British developmental biologist noted for her contributions to mammalian development, stem cell research and transgenic technology and techniques. She is currently a Professor in the Department of Cell Biology at Duke University, Born in the UK, she became an American citizen in 2000.
Peter S. Kim is an American scientist. He was president of Merck Research Laboratories (MRL) 2003–2013 and is currently Virginia & D.K. Ludwig Professor of Biochemistry at Stanford University, Institute Scholar at Stanford ChEM-H, and Lead Investigator of the Infectious Disease Initiative at the Chan Zuckerberg Biohub.
The Koch Institute for Integrative Cancer Research at MIT is a cancer research center affiliated with the Massachusetts Institute of Technology (MIT) located in Cambridge, Massachusetts, United States. The institute is one of seven National Cancer Institute-designated basic laboratory cancer centers in the United States.
Angelika Amon was an Austrian American molecular and cell biologist, and the Kathleen and Curtis Marble Professor in Cancer Research at the Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts, United States. Amon's research centered on how chromosomes are regulated, duplicated, and partitioned in the cell cycle. Amon was elected to the American Academy of Arts and Sciences in 2017.
Aviv Regev is a computational biologist and systems biologist and Executive Vice President and Head of Genentech Research and Early Development in Genentech/Roche. She is a core member at the Broad Institute of MIT and Harvard and professor at the Department of Biology of the Massachusetts Institute of Technology. Regev is a pioneer of single cell genomics and of computational and systems biology of gene regulatory circuits. She founded and leads the Human Cell Atlas project, together with Sarah Teichmann.
Bruce William Stillman, AO, FAA, FRS is a biochemist and cancer researcher who has served as the Director of Cold Spring Harbor Laboratory (CSHL) since 1994 and President since 2003. He also served as the Director of its NCI-designated Cancer Center for 25 years from 1992 to 2016. During his leadership, CSHL has been ranked as the No. 1 institution in molecular biology and genetics research by Thomson Reuters. Stillman's research focuses on how chromosomes are duplicated in human cells and in yeast Saccharomyces cerevisiae; the mechanisms that ensure accurate inheritance of genetic material from one generation to the next; and how missteps in this process lead to cancer. For his accomplishments, Stillman has received numerous awards, including the Alfred P. Sloan, Jr. Prize in 2004 and the 2010 Louisa Gross Horwitz Prize, both of which he shared with Thomas J. Kelly of Memorial Sloan-Kettering Cancer Center, as well as the 2019 Canada Gairdner International Award for biomedical research, which he shared with John Diffley.
Stephen Joseph Elledge is an American geneticist. He is the current Gregor Mendel Professor of Genetics and of Medicine at the Department of Genetics of Harvard Medical School and in the Division of Genetics of the Brigham and Women's Hospital. His research is focused on the genetic and molecular mechanisms of eukaryotic response to DNA damage, and is known as the discoverer of the DNA damage response (DDR).
Mark Andrew Lemmon an English-born biochemist, is the Alfred Gilman Professor and Department Chair of Pharmacology at Yale University where he also directs the Cancer Biology Institute.
Michael Green was an American molecular biologist and cell biologist at the University of Massachusetts Medical School, where he was the chair of the Department of Molecular, Cell and Cancer Biology, director of the UMass Cancer Center, and a Howard Hughes Medical Institute investigator. Green was a member of the National Academy of Sciences and the National Academy of Medicine.
Kairbaan Hodivala-Dilke, FMedSci is an English cell biologist who has made significant contributions to the understanding of the cellular and molecular biology of the tumour microenvironment and in particular angiogenesis. She is Professor of Angiogenesis and the Tumour Microenvironment and Deputy Institute Director of Barts Cancer Institute, Queen Mary University of London. In 2015 she was awarded the Hooke medal from the British Society for Cell Biology and EMBO membership.